GO:0062080 inhibitory MHC class Ib receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0062080 (inhibitory MHC class Ib receptor activity) is a molecular function defined as combining with an MHC class Ib protein complex to mediate signaling that inhibits lymphocyte activation.
• MHC class Ib molecules such as HLA-E in humans and H2-Q10 in mice are nonclassical MHC proteins that can serve as ligands for inhibitory receptors on NK and T cells.
• Inhibitory MHC class Ib receptors include Ly49 family members in rodents and KIR/NKG2A in humans, which deliver negative signals through ITIM motifs.
• Peptide identity, especially the P2 anchor residue, can determine whether a class Ib complex is recognized by a given inhibitory receptor.
• This receptor activity is central to NK cell education, alloreactivity, and immune tolerance, with implications for cancer immunotherapy and transplantation.
• Experimental dissection relies on knockout, point-mutation, knock-in, and overexpression models combined with cytotoxicity, signaling, and ligand-binding assays.
Description
GO:0062080 inhibitory MHC class Ib receptor activity is a molecular function in which a receptor binds an MHC class Ib protein complex and transduces a signal that suppresses lymphocyte activation. MHC class Ib molecules are nonclassical MHC class I proteins that present restricted peptides and are recognized by specialized inhibitory receptors on natural killer (NK) cells and subsets of T cells. This function is essential for preventing inappropriate immune responses against healthy cells and for shaping NK cell responsiveness. Researchers study this activity to understand immune tolerance, alloreactivity, and the design of therapies that harness inhibitory checkpoints. The QuickGO definition specifies that the receptor combines with an MHC class Ib protein complex to mediate signaling that inhibits activation of a lymphocyte, distinguishing it from activating receptors that recognize similar ligands.
inhibitory MHC class Ib receptor activity At A Glance
| GO ID | GO:0062080 |
|---|---|
| GO term | inhibitory MHC class Ib receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to an MHC class Ib protein complex to deliver inhibitory signaling in lymphocytes |
| Ligand class | Nonclassical MHC class Ib molecules (e.g., HLA-E, H2-Q10) |
| Receptor families | Ly49 (rodents), KIR/NKG2A (humans), and related inhibitory receptors |
| Signaling motif | ITIM-dependent recruitment of phosphatases |
| Cell types | NK cells, subsets of T cells, and other lymphocytes |
What Is GO:0062080?
In simple terms, GO:0062080 describes a receptor that grabs onto an MHC class Ib molecule and sends a 'stop' signal into a lymphocyte. According to the QuickGO definition, this molecular function involves combining with an MHC class Ib protein complex to mediate signaling that inhibits activation of a lymphocyte. MHC class Ib proteins are nonclassical MHC class I molecules, such as HLA-E in humans and H2-Q10 in mice, that often present specific peptides. Inhibitory receptors with this activity typically contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that recruit phosphatases to dampen activating signals. The function is defined by both ligand specificity (MHC class Ib complex) and signaling outcome (inhibition of lymphocyte activation), not merely by binding.
Why Is inhibitory MHC class Ib receptor activity Important in Cell Biology?
GO:0062080 is important because inhibitory MHC class Ib receptor activity sets the threshold for lymphocyte activation and is a key mechanism of self-tolerance. Dysregulation of this activity can lead to autoimmunity, impaired pathogen clearance, or failure to control tumors. Understanding how class Ib ligands are recognized, including peptide-dependent effects, informs vaccine design, transplantation strategies, and cancer immunotherapy.
• Controls NK cell education and licensing, influencing responsiveness to target cells.
• Prevents autoaggression by delivering inhibitory signals upon recognition of self MHC class Ib molecules.
• Modulates NK cell alloreactivity in transplantation settings.
• Peptide identity in the class Ib groove can tune receptor engagement and signaling strength.
• Provides a checkpoint axis that tumors can exploit to evade NK cell killing.
• Informs development of blocking antibodies or engineered receptors for immunotherapy.
• Relevant to viral infections where class Ib expression is altered.
• Serves as a model for understanding ITIM-based inhibitory signaling.
• Guides CRISPR-based engineering of NK cells for enhanced anti-tumor activity.
• Links structural immunology to functional outcomes in lymphocyte activation.
Molecular Mechanism of inhibitory MHC class Ib receptor activity
Ligand recognition and binding
In simple terms: The receptor first docks onto an MHC class Ib molecule on another cell.
Inhibitory MHC class Ib receptors bind nonclassical MHC class I complexes, such as HLA-E in humans and H2-Q10 in mice. Recognition can depend on the peptide cargo, including the P2 anchor residue, which alters the ligand surface presented to the receptor. In rodents, Ly49 inhibitory receptors recognize class Ib-encoded ligands with specificity that can differ between closely related receptors.
ITIM phosphorylation and phosphatase recruitment
In simple terms: Once bound, the receptor's tail gets tagged, recruiting enzymes that shut down activation.
Inhibitory receptors typically carry immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in their cytoplasmic domains. Ligand engagement leads to ITIM phosphorylation by Src-family kinases, creating docking sites for phosphatases such as SHP-1 and SHP-2. These phosphatases dephosphorylate key activating intermediates, thereby dampening lymphocyte activation.
Signal integration with activating receptors
In simple terms: The inhibitory signal competes with activating signals to set the cell's response threshold.
NK cell activation is determined by the balance between activating and inhibitory signals. Inhibitory MHC class Ib receptor activity can override activating receptor signaling when engaged by cognate class Ib ligands. This integration ensures that healthy cells expressing sufficient class Ib molecules are spared, while target cells with reduced class Ib expression become susceptible.
Peptide-dependent modulation
In simple terms: The peptide sitting in the MHC groove can change how well the receptor binds.
The identity of the peptide bound to MHC class Ib can critically affect receptor recognition. For example, the P2 anchor amino acid of the bound peptide influences recognition by a rat Ly49 NK cell receptor. This peptide sensitivity allows the immune system to discriminate between different cellular states based on the peptidome presented by class Ib molecules.
Membrane organization and triggering
In simple terms: Receptor location and clustering on the cell surface affect signaling.
Ligand-induced segregation from large cell-surface phosphatases such as CD45 is a critical step in T cell receptor triggering. Although this mechanism was described for γδ TCR, similar principles of membrane organization may influence inhibitory receptor signaling. The spatial arrangement of receptors and phosphatases can therefore modulate the strength of inhibitory outputs.
Key Genes Involved in GO:0062080 inhibitory MHC class Ib receptor activity
The following genes and proteins are central to inhibitory MHC class Ib receptor activity, based on published studies of Ly49 receptors, HLA-E, and related molecules.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Ly49i5 (rat) | Inhibitory Ly49 receptor recognizing nonclassical MHC class Ib ligands | Model for opposing functions of paired Ly49 receptors |
| Ly49s5 (rat) | Stimulatory Ly49 receptor with structural similarity to Ly49i5 | Comparison of activating versus inhibitory recognition |
| HLA-E (human) | Nonclassical MHC class Ib molecule presenting peptides to NK and T cells | Ligand for inhibitory receptors; peptide-dependent recognition |
| H2-Q10 (mouse) | Nonclassical MHC class Ib molecule | Ligand for CD8αβ and inhibitory receptors; ribosylation-dependent binding |
| KIR2DL4 (human) | Inhibitory killer-cell immunoglobulin-like receptor | Paired inhibitory receptor for HLA class I |
| NKG2A (human) | Inhibitory receptor for HLA-E | Checkpoint for NK and T cell inhibition |
| CD94 (human) | Forms heterodimer with NKG2A | Required for HLA-E recognition |
| Ly49i5 ligand (rat) | Class Ib-encoded target ligand | Defines specificity of inhibitory signaling |
| Ly49s5 ligand (rat) | Class Ib-encoded target ligand | Defines specificity of stimulatory signaling |
| SHP-1 (PTPN6) | Phosphatase recruited to ITIMs | Mediates inhibitory signaling downstream of receptor engagement |
| SHP-2 (PTPN11) | Phosphatase recruited to ITIMs | Contributes to inhibitory signal transduction |
| CD8αβ (mouse) | Coreceptor binding H2-Q10 | Ribosylation permits nonclassical MHC binding |
| γδ TCR (mouse) | T cell receptor | Ligand-induced segregation from phosphatases |
| CD45 (mouse) | Large cell-surface phosphatase | Regulates TCR triggering by segregation |
| Ly49 family (rat) | Inhibitory and stimulatory receptors | Model system for MHC class Ib recognition |
| HLA class I (human) | Classical and nonclassical MHC molecules | Paired inhibitory and triggering receptors |
| β2-microglobulin (human) | Light chain of MHC class I | Required for class Ib complex assembly and surface expression |
How Is inhibitory MHC class Ib receptor activity Regulated?
Inhibitory MHC class Ib receptor activity is regulated at multiple levels. Ligand availability depends on MHC class Ib expression and peptide loading, which can be altered by infection or cellular stress. Receptor surface levels and ITIM phosphorylation are controlled by kinases and phosphatases. Membrane organization, including segregation from large phosphatases like CD45, can modulate signaling strength. Additionally, the balance with activating receptors determines the net outcome of lymphocyte activation.
inhibitory MHC class Ib receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HLA-E | Cancer immune evasion | Knockout of HLA-E in tumor cells; NK cytotoxicity assays |
| NKG2A | Cancer immunotherapy target | Knockout or blocking antibody in NK cells |
| Ly49i5 | NK cell alloreactivity | Knockout rats; transplantation models |
| H2-Q10 | CD8αβ T cell recognition | Knock-in mice with mutated H2-Q10 |
| KIR2DL4 | Reproductive immunology and cancer | Overexpression in NK cell lines |
Cancer immune evasion
Tumors can exploit inhibitory MHC class Ib receptor activity to evade NK cell killing. Upregulation of HLA-E or other class Ib molecules can engage inhibitory receptors such as NKG2A, dampening anti-tumor responses. Blocking this axis is a promising immunotherapy strategy.
Transplantation and alloreactivity
Inhibitory MHC class Ib receptor activity influences NK cell alloreactivity, which affects graft acceptance or rejection. Mismatches in class Ib ligands can alter the balance of inhibition and activation, impacting transplant outcomes.
Autoimmunity and tolerance
Proper inhibitory signaling through class Ib receptors helps maintain self-tolerance. Defects in this pathway could contribute to autoimmunity by lowering the threshold for lymphocyte activation.
Infection and viral immune modulation
Viruses may modulate MHC class Ib expression or peptide presentation to evade inhibitory receptor recognition. Understanding these interactions can inform antiviral strategies.
From inhibitory MHC class Ib receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of inhibitory receptor enhance NK killing? | Knockout of Ly49i5 or NKG2A in NK cells |
| How does peptide identity affect receptor binding? | Point mutations in MHC class Ib peptide anchor residues |
| Can a tagged receptor track surface dynamics? | Knock-in of fluorescent tag on inhibitory receptor |
| Does overexpression of class Ib ligand suppress activation? | Overexpression of HLA-E or H2-Q10 in target cells |
| What is the role of ITIM phosphorylation? | Point mutation of ITIM tyrosines to phenylalanine |
| How does receptor segregation from phosphatases affect signaling? | Knock-in of CD45 mutants or receptor mutants |
How to Study the inhibitory MHC class Ib receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NK cytotoxicity assay | Target cell killing | Assess inhibitory receptor function |
| MHC tetramer staining | Receptor-ligand binding | Determine specificity for class Ib complexes |
| Immunoprecipitation/Western blot | ITIM phosphorylation and phosphatase recruitment | Dissect inhibitory signaling |
| Flow cytometry | Surface expression of receptors and ligands | Quantify class Ib and receptor levels |
| TIRF microscopy | Membrane organization and segregation | Visualize receptor-phosphatase dynamics |
| CRISPR knockout screening | Gene requirement for inhibitory activity | Identify novel regulators |
| RNA-seq | Transcriptional changes upon receptor engagement | Profile lymphocyte activation states |
| Proteomics | Protein interactions and post-translational modifications | Map inhibitory receptor complexes |
Cytotoxicity and activation assays
NK cell cytotoxicity assays measure the functional outcome of inhibitory MHC class Ib receptor activity. Target cells expressing class Ib ligands are used to assess whether inhibitory signals suppress killing. These assays can be combined with blocking antibodies or CRISPR knockouts to dissect receptor contributions.
Ligand binding and tetramer staining
MHC class Ib tetramers can detect receptor binding by flow cytometry. Peptide variants are used to test how anchor residues affect recognition. This method quantifies surface receptor engagement and specificity.
Signaling and phosphatase recruitment
Immunoprecipitation and immunoblotting can assess ITIM phosphorylation and SHP-1/SHP-2 recruitment. Phospho-specific antibodies reveal activation states of downstream targets. These methods link receptor engagement to biochemical signaling.
Imaging and membrane dynamics
Live-cell imaging of fluorescently tagged receptors and phosphatases reveals spatial organization at the immune synapse. Total internal reflection fluorescence (TIRF) microscopy can visualize segregation events. These approaches clarify how membrane organization tunes inhibitory signaling.
How CRISPR Can Be Used to Study GO:0062080 inhibitory MHC class Ib receptor activity
Knockout
CRISPR knockout of inhibitory MHC class Ib receptors, such as Ly49i5 or NKG2A, can abolish inhibitory signaling and enhance lymphocyte activation. Knockout of MHC class Ib ligands like HLA-E or H2-Q10 in target cells tests their role in suppressing NK or T cell responses. These models are essential for establishing causality in immune regulation.
Point Mutation
Point mutations in ITIM tyrosines of inhibitory receptors can prevent phosphatase recruitment and convert them into non-signaling proteins. Mutating peptide anchor residues in MHC class Ib molecules reveals how ligand identity affects receptor recognition. Such models fine-tune structure-function relationships.
Knock-in
Knock-in of fluorescent tags or epitope tags on inhibitory receptors allows tracking of surface dynamics and localization. Knock-in of mutated MHC class Ib genes can model disease-associated variants. These models enable precise interrogation of receptor behavior in vivo.
Overexpression
Overexpression of MHC class Ib ligands in target cells can enhance inhibitory signaling and protect from NK killing. Overexpression of inhibitory receptors in NK cell lines can amplify signaling for biochemical studies. These systems help quantify dose-dependent effects.
How EDITGENE Supports inhibitory MHC class Ib receptor activity Research
Researchers studying inhibitory MHC class Ib receptor activity-related genes often need to determine whether a candidate gene is causally involved in lymphocyte inhibition, ligand recognition, or downstream signaling. EDITGENE provides tailored CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for inhibitory MHC class Ib receptor activity research.
Frequently Asked Questions About inhibitory MHC class Ib receptor activity
What is inhibitory MHC class Ib receptor activity?
It is a molecular function (GO:0062080) where a receptor binds an MHC class Ib protein complex and signals to inhibit lymphocyte activation.
What genes are involved in inhibitory MHC class Ib receptor activity?
Key genes include HLA-E, H2-Q10, NKG2A, CD94, KIR2DL4, and rodent Ly49 inhibitory receptors such as Ly49i5.
How does inhibitory MHC class Ib receptor signaling work?
Ligand binding triggers ITIM phosphorylation, recruiting phosphatases like SHP-1/SHP-2 that dampen activating signals.
What is the role of HLA-E in this process?
HLA-E is a nonclassical MHC class Ib molecule that presents peptides to inhibitory receptors such as NKG2A, suppressing NK and T cell activation.
Why is peptide identity important for MHC class Ib recognition?
The peptide, especially the P2 anchor residue, can alter the ligand surface and determine whether a receptor binds and inhibits.
What diseases are linked to inhibitory MHC class Ib receptor activity?
Cancer immune evasion, transplantation alloreactivity, autoimmunity, and viral infections are associated with this pathway.
How can CRISPR help study inhibitory MHC class Ib receptors?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of receptor and ligand functions in immune cells.
What methods measure inhibitory MHC class Ib receptor activity?
NK cytotoxicity assays, tetramer staining, immunoblotting for ITIM phosphorylation, and imaging of membrane dynamics are commonly used.
What is the difference between inhibitory and activating MHC class Ib receptors?
Inhibitory receptors carry ITIMs and suppress activation, while activating receptors lack ITIMs and trigger stimulatory signals, as seen with paired Ly49 receptors.
Can inhibitory MHC class Ib receptors be targeted for cancer therapy?
Yes, blocking inhibitory receptors like NKG2A or their ligands can enhance NK cell anti-tumor activity and is under clinical investigation.
Conclusion
GO:0062080 inhibitory MHC class Ib receptor activity is a fundamental molecular function that restrains lymphocyte activation through recognition of nonclassical MHC class Ib complexes. Its study illuminates basic immunology and offers therapeutic opportunities in cancer, transplantation, and autoimmunity. CRISPR-based models are indispensable for dissecting the precise roles of receptors, ligands, and signaling motifs in this pathway.
References
- 1. Naper C et al.. 2005. Two structurally related rat Ly49 receptors with opposing functions (Ly49 stimulatory receptor 5 and Ly49 inhibitory receptor 5) recognize nonclassical MHC class Ib-encoded target ligands.. J Immunol 174(5):2702-11 PMID: 15728478
- 2. Dai KZ et al.. 2018. Identification of MHC Class Ib Ligands for Stimulatory and Inhibitory Ly49 Receptors and Induction of Potent NK Cell Alloresponses in Rats.. J Immunol 200(8):2847-2859 PMID: 29531166
- 3. Pietra G et al.. 2009. HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.. Curr Pharm Des 15(28):3336-44 PMID: 19860683
- 4. Ma BJ et al.. 2011. Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide.. J Immunol 187(6):3267-76 PMID: 21841133
- 5. López-Botet M et al.. 2000. Paired inhibitory and triggering NK cell receptors for HLA class I molecules.. Hum Immunol 61(1):7-17 PMID: 10658973
- 6. Goodall KJ et al.. 2021. Ribosylation of the CD8αβ heterodimer permits binding of the nonclassical major histocompatibility molecule, H2-Q10.. J Biol Chem 297(4):101141 PMID: 34478713
- 7. Li F et al.. 2024. Ligand-induced segregation from large cell-surface phosphatases is a critical step in γδ TCR triggering.. Cell Rep 43(9):114761 PMID: 39276348
- 8. Makrigiannis AP et al.. 2003. Regulation of natural killer cell function.. Cancer Biol Ther 2(6):610-6 PMID: 14688463
